New Haven, CT, Aug 01, 2018 – NorthEast BioLab, a boutique bioanalytical services contract research organization (CRO), today announced expansion of their laboratory facilities.
“We are committed to investing in technology and infrastructure that will strengthen our value proposition. NorthEast BioLab is expanding its facilities to efficiency fulfill our rising service demand”, commented Dr. Vipin Agarwal, President & CEO of NorthEast BioLab. These additions expand upon the Company’s established facilities in New Haven, CT.
NorthEast BioLab is scaling its operations to ensure continued customer satisfaction. The new facilities address the company’s strong growth. Simultaneously, the team aims to maintain their high-quality service as well as regulatory and quality control standards. It seems NorthEast BioLab’s now better equipped to provide uninterrupted and faster turnaround, helping in turn accelerate development and research efforts of their clients.
“Our clients’ support and continued partnership is critical for our Company. We thank them and look forward to new growth opportunities in the near future. Moreover, we invite all current and potential clients to learn more about us. Finally, we welcome the opportunity to discuss any questions or concerns”, said Abhay Pandey, VP of Business and Corporate Development.
NorthEast BioAnalytical Laboratories LLC
NorthEast BioLab is a boutique CRO providing tailored R&D services to biotechnology and pharmaceutical companies. Our team specializes in developing LC-MS methods and analyzing biological samples for drug discovery and development. We have a 15+ years’ distinctive track record of successfully collaborating with emerging disruptors, leading incumbents, as well as scientific and academic fraternity across the healthcare sector.
We are passionate scientists streamlining the discovery of life enhancing treatments. Above all, we expedite the achievement of your various drug research and development milestones.
Our mission driven team has extensive expertise in pharmacokinetic and bioananlytical analyses, immunochemistry, drug discovery and research, and clinical sample management and storage services. Our capabilities include bioanalytical method development, validation, optimization, biological sample analysis, and metabolite identification. We have a wide variety of validated analytical methods and diagnostic tools to support drug development from the early discovery stages to late stage clinical trials.